A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis

B.J.F. van den Bemt, K. Vos, A.A. den Broeder, M. Blom, R.M. Thurlings, G.M. Bartelds, S.O. Stapel, P. Barrera, P.P. Tak, M.T. Nurmohamed, G. Wolbink

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)1368-1369
Number of pages3
JournalAnnals of the rheumatic diseases
Issue number8
Publication statusPublished - 2009

Cite this